Also found in: Medical, Wikipedia.
LCKLock (street type)
LCKLymphocyte-Specific Protein-Tyrosine Kinase
LCKLim Chu Kang (Singapore)
LCKLai Chi Kok (Hong Kong)
LCKLens Cleaning Kit (cameras)
LCKLibrary Construction Kit (Microsoft)
References in periodicals archive ?
Cr(VI)-stimulated STAT3 tyrosine phosphorylation and nuclear translocation in human airway epithelial cells requires Lck.
5] Human genes: CD2, CD2 molecule; CD3E, CD3e molecule, e (CD3-TCR complex); LCK, lymphocyte-specific protein tyrosine kinase; GZMA, granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3); CD28, CD28 molecule; MNDA, myeloid cell nuclear differentiation antigen; LYN, v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; MYC, v-myc myelocytomatosis viral oncogene homolog (avian); BTG1, B-cell translocation gene 1, anti-proliferafive; CD79A, CD79a molecule, immunoglobulin-associated a; FAIM3, Fas apoptotic inhibitory molecule 3; CCR7, chemokine (C-C mofif) receptor 7; CD48, CD48 molecule; HLA-DRA, major histocompatibility complex, class II, DR a; FCER2, Fc fragment of IgE, low affinity II, receptor for (CD23); CD52, CD52 molecule.
Sample quantities of the LCK 4953 are available now with production scheduled for mid-October.
143-146) One study has suggested Serpine10 and BIN1 as potential markers and BST2 and LCK as potential therapeutic molecular targets.
1A), we have developed a highly sensitive homogeneous assay for lck kinase ([p56.
Nathan stats will be reduced, both at start and in the increase with each level - except for LCK (Luck).
Once the data has been collated and evaluated we will provide it to our independent resource estimation consultant who has been engaged to construct JORC compliant coal resource modelling and other geological sendees to LCK.
25, 2013 /PRNewswire/ -- HighTower, the nation's destination of choice for entrepreneurial advisors seeking greater independence and practice control, announces the transition of LCK Wealth Management to the HighTower partnership.
Lck SH3 domain function is required for T-cell receptor signals regulating thymocyte development.
Transgenic mice expressing v-Rel under the control of the lck T-cell-specific promoter develop T-cell lymphomas.
Gleevec, marketed by Novartis Pharmaceuticals Corporation for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), was found to bind tightly to a kinase known as LCK, a key regulator of T-cell maturation and activation, indicating that Gleevec or close derivatives may be clinically useful as an immunosuppressant.
SPRYCEL is the first approved oral multiple tyrosine kinase inhibitor that, at nanomolar concentrations, inhibits BCR-ABL, SRC family (SRC, LCK, YES, FYN), c-KIT, EPHA2, and PDGFRBeta kinases.